Closed System Transfer Devices Market Analysis and Forecast to 2031: By Closing Mechanism (Push-to-Lock System, Click-to-Lock System, Luer Lock System, Color-to-Color Alignment System), Type (Membrane to Membrane Systems, Needleless Systems), Component (V
Description
Closed System Transfer Devices Market Analysis and Forecast to 2031: By Closing Mechanism (Push-to-Lock System, Click-to-Lock System, Luer Lock System, Color-to-Color Alignment System), Type (Membrane to Membrane Systems, Needleless Systems), Component (Vial Access Devices, Syringe Safety Devices, Bag/Line Access Devices, Accessories), End User (Hospitals & Clinics, Oncology Centers, Others), and Region
The global closed system transfer devices market was valued at USD 914.0 Million in 2021 and it is anticipated to grow at 18.1% CAGR during the forecast period to reach up to USD 4834.1 Million by 2031.
A closed system transfer device or "CSTD" is a drug transfer device, which mechanically restricts the transfer of environmental contamination in the medical system and the escape of hazardous drug or vapor concentrations outside the system. Open versus closed systems are commonly applied in medical devices to maintain the sterility of a fluid pathway. CSTDs work by preventing- uncontrolled inflow and outflow of contaminants and drugs, preserving the quality of the solution to be infused into a patient. These devices ensure the safety of healthcare workers during the usage of hazardous drugs or chemicals. Closed system transfer device designs and models have changed at a rapid rate in recent years, resulting in the development of a number of independent testing methodologies to assess closed system transfer device performance. Currently, manufacturers in the closed system transfer devices market are focusing more on adhering to performance requirements, which largely focus on patient safety and sterile practices.
Global Closed System Transfer Devices Market Scope and Report Structure
Market Trends and Drivers
The key factors such as rising use of CSTDs to combat the harmful effect of cytotoxic and antineoplastic drugs. Antineoplastic drugs are widely used in the treatment of cancer and are considered hazardous drugs. Healthcare workers involved in the preparation, transport, distribution, administration (pre and post-administration), and disposal of these drugs are at extremely high risk. The National Institute for Occupational Safety and Health (NIOSH) recommends the use of CSTDs to eliminate the harmful effects caused by exposure to hazardous substances that escape out of the system during drug preparation and administration. CSTDs act as a barrier and prevents the entry of contaminants prevent the transfer of contaminants from the atmosphere to a sterile environment. Due to these advantages, CSTDs are increasingly being used in healthcare facilities to combat the harmful effects of hazardous drugs.
Chemotherapy, a widely adopted cancer treatment, uses one or more antineoplastic drugs, which destroy abnormal cells in patients. The use of closed system transfer devices (CSTDs) in conjunction with other safety precautions such as gloves, gowns, masks, and vented preparation hoods is an effective way to increase safety when preparing, transporting, administering, and disposing of hazardous drugs. With the increasing incidence of cancer and increasing adoption of chemotherapy treatments, the demand for CSTDs is expected to increase in the upcoming years.
Market Restraints and Challenges
The major factor hindering the market growth is the high cost of implementation of CSTDs and lack of reimbursement. The cost of a closed system transfer device is one of the major constraints limiting its adoption in healthcare facilities. The cost of a typical CSTD primarily depends upon factors like manufacturer, components used, and drug that is to be administered. Moreover, since CSTDs are meant for single-use, the cost per unit is higher than regular syringes. The median price of CSTD ranges between USD8-12 per dose. According to the regulatory guidelines, CSTDs are categorized as IV consumables. Its usage is not mandatory in European and other developing nations. Since the use of these devices is absolutely voluntary in these countries, its reimbursement is unlikely. Hence, the lack of standard guidelines further acts as a hindrance to the adoption of these devices.
Global Closed System Transfer Devices Market Segmentation
The report analyses the global closed system transfer devices market based on closing mechanism, type, component, end user, and region.
Global Closed System Transfer Devices Market by Closing Mechanism
Based on the closing mechanism, it is segmented into the push to lock system, click to lock system, Luer lock system, and color to color alignment system. Color to color alignment system is likely to dominate the market during the forecast period. Owing to its unique structure that prevents leaks, spills, or the escape of vapors and aerosols. These devices equalize the pressure within the system when fluids are withdrawn or injected into vials. Additionally, the low cost of this system, along with its advantages, increased its adoption among pharmacists, oncologists, and nurses.
Global Closed System Transfer Devices Market by Type
Based on type, it is segmented into the membrane to membrane systems, and needleless systems. The membrane to membrane system is anticipated to dominate the market during the forecast period. The key factors such as ease of operation and lower risk of contamination associated with double membrane containment systems are boosting the market growth.
Global Closed System Transfer Devices Market by Component
Based on component, it is segmented into vial access devices, syringe safety devices, bag/line access devices, and accessories. The vial access devices segment is estimated to dominate the market during the forecast period. The key factors such as rising adoption of CSTDs products and vial access device by oncology nurses to transfer hazardous drugs from packaged vials to the infusion bag or the patient.
Global Closed System Transfer Devices Market by End User
Based on end user, it is segmented into hospitals & clinics, oncology centers, and other end users. The hospitals & clinics segment is likely to dominate the market during the forecast period. The large share and high growth of this segment are primarily owing to the strong financial capabilities of hospitals for purchasing high-priced CSTDs, the large cancer patient pool, and the need to comply with regulatory guidelines.
Geographical Analysis of Closed System Transfer Devices Market
Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. North America is likely to dominate the market during the forecast period. The key factors such as easy accessibility to advanced technologies, high awareness about CSTD among oncologists, nurses, and pharmacists, and the presence of many CSTD manufacturing players in the region coupled with high incidences of cancer.
Major Players in Closed System Transfer Devices Market
COVID-19 Impact
The outbreak of COVID-19 led to a decrease in the demand for CSTDs during the first two quarters of 2020. Due to the virus containment norms and nationwide lockdowns, there were limited patient footfalls in hospitals, mostly related to COVID-19 and emergency cases. The elective medical procedures are on hold thereby causing a negative shift in the demand for CSTDs. Still, with the decline in the number of active COVID-19 cases coupled with the economic recovery in developed nations, further utilization of these devices may be expected in the near future.
Recent Developments
Please Note: This report will be delivered by publisher within 3-4 business days of order confirmation.
The global closed system transfer devices market was valued at USD 914.0 Million in 2021 and it is anticipated to grow at 18.1% CAGR during the forecast period to reach up to USD 4834.1 Million by 2031.
A closed system transfer device or "CSTD" is a drug transfer device, which mechanically restricts the transfer of environmental contamination in the medical system and the escape of hazardous drug or vapor concentrations outside the system. Open versus closed systems are commonly applied in medical devices to maintain the sterility of a fluid pathway. CSTDs work by preventing- uncontrolled inflow and outflow of contaminants and drugs, preserving the quality of the solution to be infused into a patient. These devices ensure the safety of healthcare workers during the usage of hazardous drugs or chemicals. Closed system transfer device designs and models have changed at a rapid rate in recent years, resulting in the development of a number of independent testing methodologies to assess closed system transfer device performance. Currently, manufacturers in the closed system transfer devices market are focusing more on adhering to performance requirements, which largely focus on patient safety and sterile practices.
Global Closed System Transfer Devices Market Scope and Report Structure
Market Trends and Drivers
The key factors such as rising use of CSTDs to combat the harmful effect of cytotoxic and antineoplastic drugs. Antineoplastic drugs are widely used in the treatment of cancer and are considered hazardous drugs. Healthcare workers involved in the preparation, transport, distribution, administration (pre and post-administration), and disposal of these drugs are at extremely high risk. The National Institute for Occupational Safety and Health (NIOSH) recommends the use of CSTDs to eliminate the harmful effects caused by exposure to hazardous substances that escape out of the system during drug preparation and administration. CSTDs act as a barrier and prevents the entry of contaminants prevent the transfer of contaminants from the atmosphere to a sterile environment. Due to these advantages, CSTDs are increasingly being used in healthcare facilities to combat the harmful effects of hazardous drugs.
Chemotherapy, a widely adopted cancer treatment, uses one or more antineoplastic drugs, which destroy abnormal cells in patients. The use of closed system transfer devices (CSTDs) in conjunction with other safety precautions such as gloves, gowns, masks, and vented preparation hoods is an effective way to increase safety when preparing, transporting, administering, and disposing of hazardous drugs. With the increasing incidence of cancer and increasing adoption of chemotherapy treatments, the demand for CSTDs is expected to increase in the upcoming years.
Market Restraints and Challenges
The major factor hindering the market growth is the high cost of implementation of CSTDs and lack of reimbursement. The cost of a closed system transfer device is one of the major constraints limiting its adoption in healthcare facilities. The cost of a typical CSTD primarily depends upon factors like manufacturer, components used, and drug that is to be administered. Moreover, since CSTDs are meant for single-use, the cost per unit is higher than regular syringes. The median price of CSTD ranges between USD8-12 per dose. According to the regulatory guidelines, CSTDs are categorized as IV consumables. Its usage is not mandatory in European and other developing nations. Since the use of these devices is absolutely voluntary in these countries, its reimbursement is unlikely. Hence, the lack of standard guidelines further acts as a hindrance to the adoption of these devices.
Global Closed System Transfer Devices Market Segmentation
The report analyses the global closed system transfer devices market based on closing mechanism, type, component, end user, and region.
Global Closed System Transfer Devices Market by Closing Mechanism
Based on the closing mechanism, it is segmented into the push to lock system, click to lock system, Luer lock system, and color to color alignment system. Color to color alignment system is likely to dominate the market during the forecast period. Owing to its unique structure that prevents leaks, spills, or the escape of vapors and aerosols. These devices equalize the pressure within the system when fluids are withdrawn or injected into vials. Additionally, the low cost of this system, along with its advantages, increased its adoption among pharmacists, oncologists, and nurses.
Global Closed System Transfer Devices Market by Type
Based on type, it is segmented into the membrane to membrane systems, and needleless systems. The membrane to membrane system is anticipated to dominate the market during the forecast period. The key factors such as ease of operation and lower risk of contamination associated with double membrane containment systems are boosting the market growth.
Global Closed System Transfer Devices Market by Component
Based on component, it is segmented into vial access devices, syringe safety devices, bag/line access devices, and accessories. The vial access devices segment is estimated to dominate the market during the forecast period. The key factors such as rising adoption of CSTDs products and vial access device by oncology nurses to transfer hazardous drugs from packaged vials to the infusion bag or the patient.
Global Closed System Transfer Devices Market by End User
Based on end user, it is segmented into hospitals & clinics, oncology centers, and other end users. The hospitals & clinics segment is likely to dominate the market during the forecast period. The large share and high growth of this segment are primarily owing to the strong financial capabilities of hospitals for purchasing high-priced CSTDs, the large cancer patient pool, and the need to comply with regulatory guidelines.
Geographical Analysis of Closed System Transfer Devices Market
Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. North America is likely to dominate the market during the forecast period. The key factors such as easy accessibility to advanced technologies, high awareness about CSTD among oncologists, nurses, and pharmacists, and the presence of many CSTD manufacturing players in the region coupled with high incidences of cancer.
Major Players in Closed System Transfer Devices Market
COVID-19 Impact
The outbreak of COVID-19 led to a decrease in the demand for CSTDs during the first two quarters of 2020. Due to the virus containment norms and nationwide lockdowns, there were limited patient footfalls in hospitals, mostly related to COVID-19 and emergency cases. The elective medical procedures are on hold thereby causing a negative shift in the demand for CSTDs. Still, with the decline in the number of active COVID-19 cases coupled with the economic recovery in developed nations, further utilization of these devices may be expected in the near future.
Recent Developments
- January 2021, Simplivia Healthcare acquired 70% of Novame d, a diagnostic company that develops and manufactures a range of diagnostic kits to meet evolving trends of home care.
- May 2021, BD expanded its drug delivery devices segment by establishing a high-tech manufacturing facility in Zaragoza, Spain.
- May 2021, Yukon Medical received US FDA clearance for Arisure closed system transfer device under the ONB product classification.
- November 2020, Equashield LLC partnered with Syntronic Hospitalar to introduce Equashield’s products in Brazil.
Please Note: This report will be delivered by publisher within 3-4 business days of order confirmation.
Table of Contents
167 Pages
- Chapter 1. Market introduction
- 1.1. Objectives of the study
- 1.2. Market definition and research & scope
- 1.3. Research methodologies
- 1.4. Market estimation techniques
- Chapter 2. Executive summary
- 2.1. Summary
- 2.2. Key highlights of the market
- Chapter 3. Closed System Transfer Devices market outlook
- 3.1. Closed System Transfer Devices market segmentation
- 3.2. Market dynamics
- 3.2.1. Market drivers
- 3.2.1.1. Driver 1
- 3.2.1.2. Driver 2
- 3.2.1.3. Driver 3
- 3.2.2. Market restraints
- 3.2.2.1. Restraint 1
- 3.2.2.2. Restraint 2
- 3.2.3. Market opportunities
- 3.2.3.1. Opportunity 1
- 3.2.3.2. Opportunity 2
- 3.3. Porter’s five forces analysis
- 3.3.1. Threat of new entrants
- 3.3.2. Threat of substitutes
- 3.3.3. Bargaining power of buyers
- 3.3.4. Bargaining power of supplier
- 3.3.5. Competitive rivalry
- 3.4. Pestle analysis
- 3.5. Value chain analysis
- 3.5.1. Raw material suppliers
- 3.5.2. Manufacturers
- 3.5.3. Wholesalers and/or retailers
- 3.6. Impact of the Russia and Ukraine war on the global Closed System Transfer Devices market
- Chapter 4. The economic impact of covid-19
- 4.1. Overall impact of covid-19
- 4.2. Impact of covid on the global Closed System Transfer Devices market
- 4.3. Economic impact analysis
- Chapter 5. Closed System Transfer Devices Market by Closing Mechanism
- 5.1. Market overview
- 5.2. Push to Lock System
- 5.2.1. Market size and forecast, 2021-2031 ($million)
- 5.2.2. Market size and forecast, by region, 2021-2031 ($million)
- 5.3. Click to Lock System
- 5.3.1. Market size and forecast, 2021-2031 ($million)
- 5.3.2. Market size and forecast, by region, 2021-2031 ($million)
- 5.4. Luer Lock System
- 5.4.1. Market size and forecast, 2021-2031 ($million)
- 5.4.2. Market size and forecast, by region, 2021-2031 ($million)
- 5.5. Color to Color Alignment System
- 5.5.1. Market size and forecast, 2021-2031 ($million)
- 5.5.2. Market size and forecast, by region, 2021-2031 ($million)
- Chapter 6. Closed System Transfer Devices market by Type
- 6.1. Market overview
- 6.2. Membrane to Membrane Systems
- 6.2.1. Market size and forecast, 2021-2031 ($million)
- 6.2.2. Market size and forecast, by region, 2021-2031 ($million)
- 6.3. Needleless Systems
- 6.3.1. Market size and forecast, 2021-2031 ($million)
- 6.3.2. Market size and forecast, by region, 2021-2031 ($million)
- Chapter 7. Cancer biomarkers market by Component
- 7.1. Market overview
- 7.2. Vial Access Devices
- 7.2.1. Market size and forecast, 2021-2031 ($million)
- 7.2.2. Market size and forecast, by region, 2021-2031 ($million)
- 7.3. Syringe Safety Devices
- 7.3.1. Market size and forecast, 2021-2031 ($million)
- 7.3.2. Market size and forecast, by region, 2021-2031 ($million)
- 7.4. Bag/Line Access Devices
- 7.4.1. Market size and forecast, 2021-2031 ($million)
- 7.4.2. Market size and forecast, by region, 2021-2031 ($million)
- 7.5. Accessories
- 7.5.1. Market size and forecast, 2021-2031 ($million)
- 7.5.2. Market size and forecast, by region, 2021-2031 ($million)
- Chapter 8. Cancer biomarkers market by End User
- 8.1. Market overview
- 8.2. Hospitals & Clinics
- 8.2.1. Market size and forecast, 2021-2031 ($million)
- 8.2.2. Market size and forecast, by region, 2021-2031 ($million)
- 8.3. Oncology Centers
- 8.3.1. Market size and forecast, 2021-2031 ($million)
- 8.3.2. Market size and forecast, by region, 2021-2031 ($million)
- 8.4. Others
- 8.4.1. Market size and forecast, 2021-2031 ($million)
- 8.4.2. Market size and forecast, by region, 2021-2031 ($million)
- Chapter 9. Closed System Transfer Devices market, by region
- 9.1. Overview
- 9.2. North America
- 9.2.1. Key market trends and opportunities
- 9.2.2. North America Closed System Transfer Devices market size and forecast by Type, 2021-2031, ($million)
- 9.2.3. North America Closed System Transfer Devices market size and forecast by end user, 2021-2031, ($million)
- 9.2.4. North America Closed System Transfer Devices market size and forecast by country, 2021-2031, ($million)
- 9.2.5. The u.s.
- 9.2.5.1. The u.s. Closed System Transfer Devices market size and forecast by Type, 2021-2031, ($million)
- 9.2.5.2. The u.s. Closed System Transfer Devices market size and forecast by end user, 2021-2031, ($million)
- 9.2.6. Canada
- 9.2.6.1. Canada Closed System Transfer Devices market size and forecast by Type, 2021-2031, ($million)
- 9.2.6.2. Canada Closed System Transfer Devices market size and forecast by end user, 2021-2031, ($million)
- 9.2.7. Mexico
- 9.2.7.1. Mexico Closed System Transfer Devices market size and forecast by Type, 2021-2031, ($million)
- 9.2.7.2. Mexico Closed System Transfer Devices market size and forecast by end user Type, 2021-2031, ($million)
- 9.3. Europe
- 9.3.1. Key market trends and opportunities
- 9.3.2. Europe Closed System Transfer Devices market size and forecast by Type, 2021-2031, ($million)
- 9.3.3. Europe Closed System Transfer Devices market size and forecast by end user, 2021-2031, ($million)
- 9.3.4. Europe Closed System Transfer Devices market size and forecast by country, 2021-2031, ($million)
- 9.3.5. Germany
- 9.3.5.1. Germany Closed System Transfer Devices market size and forecast by Type, 2021-2031, ($million)
- 9.3.5.2. Germany Closed System Transfer Devices market size and forecast by end user, 2021-2031, ($million)
- 9.3.6. France
- 9.3.6.1. France Closed System Transfer Devices market size and forecast by Type, 2021-2031, ($million)
- 9.3.6.2. France Closed System Transfer Devices market size and forecast by end user, 2021-2031, ($million)
- 9.3.7. U.k.
- 9.3.7.1. U.k. Closed System Transfer Devices market size and forecast by Type, 2021-2031, ($million)
- 9.3.7.2. U.k. Closed System Transfer Devices market size and forecast by end user, 2021-2031, ($million)
- 9.3.8. Spain
- 9.3.8.1. Spain Closed System Transfer Devices market size and forecast by Type, 2021-2031, ($million)
- 9.3.8.2. Spain Closed System Transfer Devices market size and forecast by end user, 2021-2031, ($million)
- 9.3.9. Italy
- 9.3.9.1. Italy Closed System Transfer Devices market size and forecast by Type, 2021-2031, ($million)
- 9.3.9.2. Italy Closed System Transfer Devices market size and forecast by end user, 2021-2031, ($million)
- 9.3.10. Russia
- 9.3.10.1. Russia Closed System Transfer Devices market size and forecast by Type, 2021-2031, ($million)
- 9.3.10.2. Russia Closed System Transfer Devices market size and forecast by end user, 2021-2031, ($million)
- 9.3.11. Rest of Europe
- 9.3.11.1. Rest of Europe Closed System Transfer Devices market size and forecast by Type, 2021-2031, ($million)
- 9.3.11.2. Rest of Europe Closed System Transfer Devices market size and forecast by end user, 2021-2031, ($million)
- 9.4. Asia-pacific
- 9.4.1. Key market trends and opportunities
- 9.4.2. Asia-pacific Closed System Transfer Devices market size and forecast by country, 2021-2031, ($million)
- 9.4.3. Asia-pacific Closed System Transfer Devices market size and forecast by Type, 2021-2031, ($million)
- 9.4.4. Asia-pacific Closed System Transfer Devices market size and forecast by end user, 2021-2031, ($million)
- 9.4.5. China
- 9.4.5.1. China Closed System Transfer Devices market size and forecast by Type, 2021-2031, ($million)
- 9.4.5.2. China Closed System Transfer Devices market size and forecast by end user, 2021-2031, ($million)
- 9.4.6. India
- 9.4.6.1. India Closed System Transfer Devices market size and forecast by Type, 2021-2031, ($million)
- 9.4.6.2. India Closed System Transfer Devices market size and forecast by end user, 2021-2031, ($million)
- 9.4.7. Japan
- 9.4.7.1. Japan Closed System Transfer Devices market size and forecast by Type, 2021-2031, ($million)
- 9.4.7.2. Japan Closed System Transfer Devices market size and forecast by end user, 2021-2031, ($million)
- 9.4.8. South Korea
- 9.4.8.1. South Korea Closed System Transfer Devices market size and forecast by Type, 2021-2031, ($million)
- 9.4.8.2. South Korea Closed System Transfer Devices market size and forecast by end user, 2021-2031, ($million)
- 9.4.9. Rest of APAC
- 9.4.9.1. Rest of APAC Closed System Transfer Devices market size and forecast by Type, 2021-2031, ($million)
- 9.4.9.2. Rest of APAC Closed System Transfer Devices market size and forecast by end user, 2021-2031, ($million)
- 9.5. Rest of the world
- 9.5.1. Key market trends and opportunities
- 9.5.2. Rest of the world Closed System Transfer Devices market size and forecast by Type, 2021-2031, ($million)
- 9.5.3. Rest of the world Closed System Transfer Devices market size and forecast by end user, 2021-2031, ($million)
- 9.5.4. Rest of the world Closed System Transfer Devices market size and forecast by country, 2021-2031, ($million)
- 9.5.5. Latin America
- 9.5.5.1. Latin America Closed System Transfer Devices market size and forecast by Type, 2021-2031, ($million)
- 9.5.5.2. Latin America Closed System Transfer Devices market size and forecast by end user, 2021-2031, ($million)
- 9.5.6. Middle east
- 9.5.6.1. Middle east Closed System Transfer Devices market size and forecast by Type, 2021-2031, ($million)
- 9.5.6.2. Middle east Closed System Transfer Devices market size and forecast by end user, 2021-2031, ($million)
- 9.5.7. Africa
- 9.5.7.1. Africa Closed System Transfer Devices market size and forecast by Type, 2021-2031, ($million)
- 9.5.7.2. Africa Closed System Transfer Devices market size and forecast by end user, 2021-2031, ($million)
- Chapter 10. Competitive landscape
- 10.1. Market overview
- 10.2. Market share analysis/key player positioning
- 10.3. Developmental strategy benchmarking
- 10.3.1. New end user development
- 10.3.2. Type launches
- 10.3.3. Business expansions
- 10.3.4. Partnerships, joint ventures, and collaborations
- 10.3.5. Mergers and acquisitions
- Chapter 11. Company profiles
- 11.1. B. Braun Holding GmbH & Co. KG
- 11.1.1. Company snapshot
- 11.1.2. Financial performance
- 11.1.3. Type offerings
- 11.1.4. Key strategic initiatives
- 11.1.5. SWOT analysis
- 11.2. Baxter International
- 11.2.1. Company snapshot
- 11.2.2. Financial performance
- 11.2.3. Type offerings
- 11.2.4. Key strategic initiatives
- 11.2.5. SWOT analysis
- 11.3. Becton, Dickinson and Company
- 11.3.1. Company snapshot
- 11.3.2. Financial performance
- 11.3.3. Type offerings
- 11.3.4. Key strategic initiatives
- 11.3.5. SWOT analysis
- 11.4. Caragen Ltd
- 11.4.1. Company snapshot
- 11.4.2. Financial performance
- 11.4.3. Type offerings
- 11.4.4. Key strategic initiatives
- 11.4.5. SWOT analysis
- 11.5. Corvida Medical
- 11.5.1. Company snapshot
- 11.5.2. Financial performance
- 11.5.3. Type offerings
- 11.5.4. Key strategic initiatives
- 11.5.5. SWOT analysis
- 11.6. Equashield
- 11.6.1. Company snapshot
- 11.6.2. Financial performance
- 11.6.3. Type offerings
- 11.6.4. Key strategic initiatives
- 11.6.5. SWOT analysis
- 11.7. FIMI Opportunity Funds (Simplivia Healthcare)
- 11.7.1. Company snapshot
- 11.7.2. Financial performance
- 11.7.3. Type offerings
- 11.7.4. Key strategic initiatives
- 11.7.5. SWOT analysis
- 11.8. ICU Medical
- 11.8.1. Company snapshot
- 11.8.2. Financial performance
- 11.8.3. Type offerings
- 11.8.4. Key strategic initiatives
- 11.8.5. SWOT analysis
- 11.9. JCB Co Ltd. (JMS Co Ltd.)
- 11.9.1. Company snapshot
- 11.9.2. Financial performance
- 11.9.3. Type offerings
- 11.9.4. Key strategic initiatives
- 11.9.5. SWOT analysis
- 11.10. Yukon Medical
- 11.10.1. Company snapshot
- 11.10.2. Financial performance
- 11.10.3. Type offerings
- 11.10.4. Key strategic initiatives
- 11.10.5. SWOT analysis
- *the list of company is subject to change during the final compilation of the report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
